Presentations to highlight preclinical data supporting the clear differentiation of Adcentrx's clinical-stage ADRX-0405 STEAP1 ADC and preclinical ADRX-0134 NaPi2b ADC SAN DIEGO, March 25, 2025 /PRNewswire/ -- Adcentrx Therapeutics ("Adcentrx"), a clinical-stage biotechnology company...
Read More Details
Finally We wish PressBee provided you with enough information of ( Adcentrx Therapeutics to Showcase Novel STEAP1 and NaPi2b ADCs with Oral and Poster Presentations at AACR 2025 )
Also on site :
- Oil prices up after reports of 3 ships on fire in Gulf of Oman near the strait of Hormuz
- Ron Taylor Passes Away
- Barbra Streisand, 83, Makes Spicy Confession About This Hollywood Icon